Literature DB >> 8175788

Functional analysis of Drosophila factor 5 (TFIIF), a general transcription factor.

D D Kephart1, B Q Wang, Z F Burton, D H Price.   

Abstract

Factor 5 is a Drosophila RNA polymerase II initiation factor that also affects the elongation phase of transcription. We have used a cDNA encoding the large subunit of factor 5 (F5a) to produce recombinant F5a (rF5a). Antibodies directed against peptides deduced from the sequence of the F5a cDNA recognized rF5a and the large subunit of factor 5 purified from Kc cells. A chimeric human/fly factor composed of the small subunit of human TFIIF (RAP30) and rF5a stimulated elongation by Drosophila RNA polymerase II when assayed using a dC-tailed template. In addition, the chimeric human/fly factor functioned during initiation in either the Drosophila or human system. Therefore, the structure of the large subunit of TFIIF is sufficiently conserved from human to fly to allow functional interaction with both the small subunit of TFIIF and RNA polymerase II from either species. Analysis of deletion mutants of F5a indicated that almost all of the protein was required for initiation while only the NH2-terminal region was required for stimulating transcriptional elongation. A comparison of our results with those obtained with RAP74 suggest that the carboxyl terminal region of the protein may be involved in interactions with RNA polymerase II or other factors during initiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175788

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter.

Authors:  T C Kuhlman; H Cho; D Reinberg; N Hernandez
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

Review 2.  Rethinking the role of TFIIF in transcript initiation by RNA polymerase II.

Authors:  Donal S Luse
Journal:  Transcription       Date:  2012-07-01

3.  The mechanism of nucleosome traversal by RNA polymerase II: roles for template uncoiling and transcript elongation factors.

Authors:  Donal S Luse; Vasily M Studitsky
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

4.  Purification of the Drosophila RNA polymerase II general transcription factors.

Authors:  R J Austin; M D Biggin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro.

Authors:  Y Zhu; T Pe'ery; J Peng; Y Ramanathan; N Marshall; T Marshall; B Amendt; M B Mathews; D H Price
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

Review 6.  The RNA polymerase II general elongation factors.

Authors:  D Reines; J W Conaway; R C Conaway
Journal:  Trends Biochem Sci       Date:  1996-09       Impact factor: 13.807

7.  The functions of TFIIF during initiation and transcript elongation are differentially affected by phosphorylation by casein kinase 2.

Authors:  Andrea Újvári; Mahadeb Pal; Donal S Luse
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

8.  Amino acid substitutions in yeast TFIIF confer upstream shifts in transcription initiation and altered interaction with RNA polymerase II.

Authors:  Mohamed A Ghazy; Seth A Brodie; Michelle L Ammerman; Lynn M Ziegler; Alfred S Ponticelli
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Dissection of transcription factor TFIIF functional domains required for initiation and elongation.

Authors:  S Tan; R C Conaway; J W Conaway
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Architecture of the RNA polymerase II-TFIIF complex revealed by cross-linking and mass spectrometry.

Authors:  Zhuo Angel Chen; Anass Jawhari; Lutz Fischer; Claudia Buchen; Salman Tahir; Tomislav Kamenski; Morten Rasmussen; Laurent Lariviere; Jimi-Carlo Bukowski-Wills; Michael Nilges; Patrick Cramer; Juri Rappsilber
Journal:  EMBO J       Date:  2010-01-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.